10-K Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 FY 2011

Filing Information

Form Type	10-K
Accession Number	`0001144204-12-018611`
Period End Date	20111231
Filing Date	20120330
Fiscal Year	2011
Fiscal Period	FY
XBRL Instance	gnpb-20111231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 57 Income Statement 59 Cash Flow Statement 127 Stockholders Equity 37

Balance Sheet 57 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$510.22K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.26K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$2.70K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.90K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.29M	USD	Point-in-time
Intellectual property licenses, accumulated amortization	`IntellectualPropertyLicensesNetOfAccumulatedAmortization`	$217.41K	USD	Point-in-time
Intellectual property licenses, accumulated amortization	`IntellectualPropertyLicensesNetOfAccumulatedAmortization`	$57.37K	USD	Point-in-time
Deposit	`DepositsAssetsCurrent`	$5.00K	USD	Point-in-time
Deposit	`DepositsAssetsCurrent`	$9.39K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.45K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.47K	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.30M	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Total current assets	`AssetsCurrent`	$524.08K	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $2,704	`PropertyPlantAndEquipmentNet`	$28.35K	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	1.80B	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $2,704	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	1.80B	shares	Point-in-time
Intellectual property licenses, net of accumulated amortization of $217,408 and $57,372	`IntellectualPropertyLicensesNet`	-	USD	Point-in-time
Intellectual property licenses, net of accumulated amortization of $217,408 and $57,372	`IntellectualPropertyLicensesNet`	$160.04K	USD	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	77.99M	shares	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	73.64M	shares	Point-in-time
Rent Deposit	`DepositsAssetsNoncurrent`	-	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	77.99M	shares	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	73.64M	shares	Point-in-time
Rent Deposit	`DepositsAssetsNoncurrent`	$16.00K	USD	Point-in-time
Total assets	`Assets`	$1.46M	USD	Point-in-time
Total assets	`Assets`	$568.43K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$30.29K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$190.05K	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	-	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$221.51K	USD	Point-in-time
Unsecured convertible promissory notes	`ConvertibleNotesPayableCurrent`	$5.00M	USD	Point-in-time
Unsecured convertible promissory notes	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$792.58K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$7.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$822.87K	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value $0.000041666; 1,800,000,000 shares authorized; 77,993,591 and 73,638,349 shares issued and outstanding, respectively	`CommonStockValue`	$3.07K	USD	Point-in-time
Common stock, par value $0.000041666; 1,800,000,000 shares authorized; 77,993,591 and 73,638,349 shares issued and outstanding, respectively	`CommonStockValue`	$3.25K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.32M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$14.59M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.68M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-27.38M	USD	Point-in-time
Total stockholder's equity (deficiency)	`StockholdersEquity`	$-12.78M	USD	Point-in-time
Total stockholder's equity (deficiency)	`StockholdersEquity`	-	USD	Point-in-time
Total stockholder's equity (deficiency)	`StockholdersEquity`	$638.09K	USD	Point-in-time
Total stockholder's equity (deficiency)	`StockholdersEquity`	$2.28K	USD	Point-in-time
Total stockholder's equity (deficiency)	`StockholdersEquity`	$-13.49K	USD	Point-in-time
Total stockholder's equity (deficiency)	`StockholdersEquity`	$61.00K	USD	Point-in-time
Total liabilities and stockholder's equity (deficiency)	`LiabilitiesAndStockholdersEquity`	$1.46M	USD	Point-in-time
Total liabilities and stockholder's equity (deficiency)	`LiabilitiesAndStockholdersEquity`	$568.43K	USD	Point-in-time

Income Statement 59 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`SalesRevenueGoodsNet`	-	USD	Annual
REVENUES	`SalesRevenueGoodsNet`	-	USD	Annual
REVENUES	`SalesRevenueGoodsNet`	-	USD	Annual
REVENUES	`SalesRevenueGoodsNet`	-	USD	17 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$14.61M	USD	Annual
Share-Based Compensation	`ShareBasedCompensation`	$114.02K	USD	Annual
Share-Based Compensation	`ShareBasedCompensation`	-	USD	Annual
Share-Based Compensation	`ShareBasedCompensation`	$14.72M	USD	17 Qtrs
Operating expenses (including $14,608,040, $114,016, $0 and $14,722,056 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$20.02M	USD	17 Qtrs
Operating expenses (including $14,608,040, $114,016, $0 and $14,722,056 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$15.77K	USD	Annual
Operating expenses (including $14,608,040, $114,016, $0 and $14,722,056 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$19.30M	USD	Annual
Operating expenses (including $14,608,040, $114,016, $0 and $14,722,056 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$643.93K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$171.48K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.76M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.93M	USD	17 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	-	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	17 Qtrs
Total costs and expenses	`OperatingExpenses`	$22.11M	USD	17 Qtrs
Total costs and expenses	`OperatingExpenses`	$15.77K	USD	Annual
Total costs and expenses	`OperatingExpenses`	$21.22M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$815.41K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-22.11M	USD	17 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-21.22M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-815.41K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-15.77K	USD	Annual
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$1.60M	USD	Annual
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	-	USD	Annual
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$-229.23K	USD	Annual
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$1.37M	USD	17 Qtrs
Interest expense	`InterestExpense`	-	USD	Annual
Interest expense	`InterestExpense`	$151.51K	USD	17 Qtrs
Interest expense	`InterestExpense`	-	USD	Annual
Interest expense	`InterestExpense`	$151.51K	USD	Annual
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.00M	USD	Annual
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.00M	USD	17 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Private placement costs	`PrivatePlacementCosts`	$1.48M	USD	17 Qtrs
Private placement costs	`PrivatePlacementCosts`	$920.31K	USD	Annual
Private placement costs	`PrivatePlacementCosts`	$563.35K	USD	Annual
Private placement costs	`PrivatePlacementCosts`	-	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-5.27M	USD	17 Qtrs
Total other income (expense)	`OtherNonoperatingIncomeExpense`	-	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-792.58K	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-4.48M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-1.61M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-25.69M	USD	Annual
NET LOSS	`NetIncomeLoss`	$-58.72K	USD	Annual
NET LOSS	`NetIncomeLoss`	$-27.38M	USD	17 Qtrs
NET LOSS	`NetIncomeLoss`	$-15.77K	USD	Annual
NET LOSS PER SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	Annual
NET LOSS PER SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	-	USD	Annual
NET LOSS PER SHARE, BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	Annual
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING; BASIC AND DILUTED	`WeightedAverageSharesOutstandingBasicAndDiluted`	65.25M	shares	Annual
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING; BASIC AND DILUTED	`WeightedAverageSharesOutstandingBasicAndDiluted`	38.10M	shares	Annual
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING; BASIC AND DILUTED	`WeightedAverageSharesOutstandingBasicAndDiluted`	75.92M	shares	Annual

Cash Flow Statement 127 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.61M	USD	Annual
Net loss	`NetIncomeLoss`	$-25.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-58.72K	USD	Annual
Net loss	`NetIncomeLoss`	$-27.38M	USD	17 Qtrs
Net loss	`NetIncomeLoss`	$-15.77K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$2.70K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$58.60K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$64.08K	USD	17 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.33K	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	17 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$1.79M	USD	Annual
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$114.02K	USD	Annual
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$1.91M	USD	17 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	-	USD	Annual
Fair value of derivative liability recorded upon issuance of warrants	`FairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants`	-	USD	Annual
Fair value of derivative liability recorded upon issuance of warrants	`FairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants`	$2.56M	USD	Annual
Fair value of derivative liability recorded upon issuance of warrants	`FairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants`	$2.56M	USD	17 Qtrs
Fair value of derivative liability recorded upon issuance of warrants	`FairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants`	-	USD	Annual
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.00M	USD	Annual
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.00M	USD	17 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Private placement costs	`PrivatePlacementCosts`	$1.48M	USD	17 Qtrs
Private placement costs	`PrivatePlacementCosts`	$920.31K	USD	Annual
Private placement costs	`PrivatePlacementCosts`	$563.35K	USD	Annual
Private placement costs	`PrivatePlacementCosts`	-	USD	Annual
Change in fair value of derivative liabilities	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$1.60M	USD	Annual
Change in fair value of derivative liabilities	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	-	USD	Annual
Change in fair value of derivative liabilities	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$-229.23K	USD	Annual
Change in fair value of derivative liabilities	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$1.37M	USD	17 Qtrs
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	Annual
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	$8.01M	USD	Annual
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	Annual
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	$8.01M	USD	17 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$498.45K	USD	17 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$498.45K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	$1.74M	USD	17 Qtrs
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	Annual
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	Annual
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	$1.74M	USD	Annual
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	Annual
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	$50.00K	USD	Annual
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	Annual
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	$50.00K	USD	17 Qtrs
Deposit	`IncreaseDecreaseInDepositsOutstanding`	$-4.85K	USD	Annual
Deposit	`IncreaseDecreaseInDepositsOutstanding`	-	USD	Annual
Deposit	`IncreaseDecreaseInDepositsOutstanding`	$-4.39K	USD	Annual
Deposit	`IncreaseDecreaseInDepositsOutstanding`	$-9.39K	USD	17 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-4.47K	USD	17 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-3.45K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-1.03K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-16.00K	USD	17 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-16.00K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$30.29K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$381.26K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-8.00	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$411.56K	USD	17 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.19M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.88M	USD	17 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-14.45K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-620.80K	USD	Annual
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.05K	USD	Annual
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$35.05K	USD	17 Qtrs
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	$50.00K	USD	Annual
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	$50.00K	USD	17 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-81.05K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-85.05K	USD	17 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$4.62M	USD	17 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$4.62M	USD	Annual
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$873.00K	USD	Annual
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.84M	USD	17 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.91M	USD	Annual
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$18.14K	USD	17 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$-4.98K	USD	Annual
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$19.80K	USD	Annual
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$19.80K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.48M	USD	17 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.49M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.91M	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.28M	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$510.22K	USD	17 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-782.25K	USD	Annual
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.35K	USD	Annual
Cash and Cash Equivalents, Beginning Of Year	`CashAndCashEquivalentsAtCarryingValue`	$510.22K	USD	Point-in-time
Cash and Cash Equivalents, Beginning Of Year	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning Of Year	`CashAndCashEquivalentsAtCarryingValue`	$8.26K	USD	Point-in-time
Cash and Cash Equivalents, Beginning Of Year	`CashAndCashEquivalentsAtCarryingValue`	$2.90K	USD	Point-in-time
Cash and Cash Equivalents, Beginning Of Year	`CashAndCashEquivalentsAtCarryingValue`	$1.29M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, End of Year	`CashAndCashEquivalentsAtCarryingValue`	$510.22K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, End of Year	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
CASH AND CASH EQUIVALENTS, End of Year	`CashAndCashEquivalentsAtCarryingValue`	$8.26K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, End of Year	`CashAndCashEquivalentsAtCarryingValue`	$2.90K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, End of Year	`CashAndCashEquivalentsAtCarryingValue`	$1.29M	USD	Point-in-time
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	$5.54M	USD	Annual
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	Annual
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	$5.54M	USD	17 Qtrs
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	Annual
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	-	USD	Annual
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$642.30K	USD	17 Qtrs
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	-	USD	Annual
Derivative liability recorded as offering cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$642.30K	USD	Annual
Common stock issued for intellectual property	`StockIssued1`	-	USD	Annual
Common stock issued for intellectual property	`StockIssued1`	$217.41K	USD	17 Qtrs
Common stock issued for intellectual property	`StockIssued1`	$217.41K	USD	Annual
Common stock issued for intellectual property	`StockIssued1`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	17 Qtrs
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	Annual

Stockholders Equity 37 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquity`	$-12.78M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	-	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$638.09K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$2.28K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$-13.49K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$61.00K	USD	Point-in-time
Initial capitalization, sale of common stock to directors, September 17, 2007, amount	`StockIssuedDuringPeriodValueNewIssues`	$8.00K	USD	1 Quarter
Private placement, closed December 31, 2007, amount	`StockIssuedDuringPeriodValueOther`	$53.00K	USD	1 Quarter
Common stock sold in private placement at $0.03125 per share, March 2010, amount	`CommonStockSoldInPrivatePlacementAt0.03125PerShareMarch2010Amount`	$365.00K	USD	Annual
Common stock issued for intellectual property, amount	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$217.41K	USD	Annual
Common stock sold in private placement at $0.75 per share, September 2010, amount	`CommonStockSoldInPrivatePlacementAt0.75PerShareSeptember2010Amount`	$700.00K	USD	Annual
Common stock sold in private placement at $1.00 per share, October 2010, amount	`CommonStockSoldInPrivatePlacementAt1.00PerShareOctober2010Amount`	$250.00K	USD	Annual
Common stock sold in private placement at $1.00 per share, December 2010, amount	`CommonStockSoldInPrivatePlacementAt1.00PerShareDecember2010Amount`	$595.00K	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	17 Qtrs
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	Annual
Common Stock sold in Private Placement at $1.00 per share, January 2011, Amount	`CommonStockSoldInPrivatePlacementAt100PerShareJanuary2011Amount`	$45.00K	USD	Annual
Common Stock sold in Private Placement at $1.00 per share, April to June 2011, Amount	`CommonStockSoldInPrivatePlacementAt1PerShareAprilToJune2011Amount`	$185.70K	USD	Annual
Common stock issued to consultants for services, Amount	`CommonStockIssuedToConsultantsForServicesAmount`	$498.45K	USD	Annual
Cancellation of shares, Amount	`CancellationOfSharesAmount`	-	USD	Annual
Fair value of common stock issued to officer for services, Amount	`FairValueOfCommonStockIssuedToOfficerForServicesAmount`	$8.01M	USD	Annual
Fair value of vested stock options and warrants	`FairValueOfVestedStockOptionsAndWarrants`	$1.79M	USD	Annual
Fair value of vested stock options and warrants	`FairValueOfVestedStockOptionsAndWarrants`	$114.02K	USD	Annual
Fair value of common stock transferred to officer	`FairValueOfCommonStockTransferredToOfficer`	$702.04K	USD	Annual
Fair value of common stock transferred from CEO to a director	`FairValueOfCommonStockTransferredFromCeoToDirector`	$1.04M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.61M	USD	Annual
Net loss	`NetIncomeLoss`	$-25.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-58.72K	USD	Annual
Net loss	`NetIncomeLoss`	$-27.38M	USD	17 Qtrs
Net loss	`NetIncomeLoss`	$-15.77K	USD	Annual
Ending Balance Amount	`StockholdersEquity`	$-12.78M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	-	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$638.09K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$2.28K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$-13.49K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$61.00K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.